NCT04643873

Brief Summary

The primary aim of our study is to evaluate the effects of physical activity counseling and pilates exercises on metabolic control variables in patients with prediabetes and type 2 diabetes; Its secondary aim is to examine the effects of both practices on physical activity level, exercise capacity and quality of life, and to compare the relationship between those under medical supervision by family doctor.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2020

Completed
26 days until next milestone

Study Start

First participant enrolled

October 30, 2020

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 25, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

October 26, 2024

Status Verified

May 1, 2023

Enrollment Period

2.2 years

First QC Date

October 4, 2020

Last Update Submit

October 22, 2024

Conditions

Keywords

exercisediabetus mellitustype 2counselingprediabetic state

Outcome Measures

Primary Outcomes (9)

  • fasting blood glucose

    A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is normal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes. If it's 126 mg/dL (7 mmol/L) or higher on two separate tests, you have diabetes percentage of body fat, amount of visceral fat, body mass index: amount of muscle mass in the trunk and extremities

    up to 12 weeks

  • HbA1c

    A hemoglobin A1c (HbA1c) test measures the amount of blood sugar (glucose) attached to hemoglobin. Normal: HbA1c below 5.7% Prediabetes: HbA1c between 5.7% and 6.4% Diabetes: HbA1c of 6.5% or higher

    up to 12 weeks

  • HDL

    HDL (high-density lipoprotein cholesterol) cholesterol: High density lipoprotein cholesterol.60 mg/dL (1.6 mmol/L) or above is desirable

    up to 12 weeks

  • LDL

    LDL (low-density lipoprotein cholesterol) Adult - \< 130 mg/dL is normal value for LDL. Low-density lipoprotein is a type of lipoprotein that consists of cholesterol (LDL cholesterol, LDL-C) and similar substances with a small amount of protein

    up to 12 weeks

  • total cholesterol

    Total cholesterol a measure of the total amount of cholesterol in your blood. It includes both low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol. Less than 200 mg/dL is normal

    up to 12 weeks

  • triglyceride values

    Triglycerides are a type of fat (lipid) found in blood. Normal is less than 150 milligrams per deciliter (mg/dL), or less than 1.7 millimoles per liter (mmol/L)

    up to 12 weeks

  • percentage of body fat

    Body fat percentage will be calculated with the Jawon X-Contact 350 device

    up to 12 weeks

  • Muscle mass amounts in the trunk and extremities

    Muscle mass amounts in the trunk and extremities will be calculated with the Jawon X-Contact 350.Muscle mass includes the skeletal muscles, smooth muscles such as cardiac and digestive muscles and the water contained in these muscles

    up to 12 weeks

  • Step number

    Average one week steps before and after intervention will be calculated with OMRON HJ 109 pedometer

    up to 12 weeks

Secondary Outcomes (9)

  • Short version of IPAQ (International Physical Activity Questionnaire)

    up to 12 weeks

  • SF36 (Short Form 36)

    up to 12 weeks

  • 6 minutes walk test

    up to 12 weeks

  • BMI (body mass index)

    up to 12 weeks

  • amount of visceral fat

    up to 12 weeks

  • +4 more secondary outcomes

Study Arms (3)

Experimental group 1

EXPERIMENTAL

physical activity counseiling +pilates exercise group

Other: physical activity counseiling +pilates exercise group

Experimental group 2

EXPERIMENTAL

only physical activity counseiling group

Behavioral: physical activity counseiling group

Control Group

NO INTERVENTION

only followed by family physician

Interventions

It is planned to do the pilates exercises for 50 minutes a day, 2 days a week during 12 weeks with physiotherapist. Pilates group patient will make pilates exercise once a week alone During physical activity counseling, considering the current physical and metabolic status of the person, the person-based 5A model of ACSM will be adapted to individuals with diabetes and physical activity consultancy will be provided

Also known as: exercise
Experimental group 1

During physical activity counseling, considering the current physical and metabolic status of the person, the person-based 5A model of ACSM will be adapted to individuals with diabetes and physical activity consultancy will be provided. Patients make aerobic and strengthening exercises by theirself based on phyiotherapist's suggestions

Experimental group 2

Eligibility Criteria

AgeUp to 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with prediabetes or Type II diabetes at most 10 years ago
  • Not using insulin
  • Being under the age of 70
  • Be woman
  • Individuals regulated by glucose control, medication and / or diet
  • Volunteering to exercise at least 3 days a week in the intervention group within the scope of the research
  • Being able to communicate in Turkish written and verbal

You may not qualify if:

  • Having uncontrolled hypertension (160/90 mmHg), cardiovascular problem, renal disease, neuropathy, systemic disease that will create contraindications for exercise
  • Body mass index over 35 kg / m²
  • Being a communication problem, not being able to cooperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Merve Suay

Hatay, 31350, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Diabetes MellitusPrediabetic StateMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • ela tarakcı, prof dr

    Istanbul University- Cerrahpasa Physiotherpy and Rehabilitation Department

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

October 4, 2020

First Posted

November 25, 2020

Study Start

October 30, 2020

Primary Completion

January 12, 2023

Study Completion

June 1, 2023

Last Updated

October 26, 2024

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations